Since its establishment in 1982, Gilde has invested in more than 250 companies. With offices in The Netherlands, France and Switzerland Gilde is one of the most prominent continental European private equity investors.
Gilde operates through specialized investment funds for buy outs and life sciences. Funds under management exceed €2 billion.
The Gilde Benelux fund focuses exclusively on realizing management buyouts of mid-market companies headquartered in the Benelux. Investments are typically made in attractive companies with a transaction size of between € 15 and € 75 million.
With offices in The Netherlands, France and Switzerland, Gilde Buy Out Partners focuses on realizing mid-market buy out transactions in the Benelux, France, Germany, Switzerland and Austria [continental Western Europe] valued between € 75 and € 600 million.
Gilde Healthcare Partners is a European venture capital firm with more than €275 million capital under management. The Fund focuses on companies engaged in the development of novel therapeutics, diagnostics, medical devices and Healthcare Services.